216 related articles for article (PubMed ID: 19681350)
1. [Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases].
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca EP; De Moor RJ; Nammour S
Rev Belge Med Dent (1984); 2009; 64(2):87-95. PubMed ID: 19681350
[TBL] [Abstract][Full Text] [Related]
2. Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT).
Vescovi P; Manfredi M; Merigo E; Meleti M; Fornaini C; Rocca JP; Nammour S
Lasers Med Sci; 2010 Jan; 25(1):101-13. PubMed ID: 19543768
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Rugani P; Acham S; Truschnegg A; Obermayer-Pietsch B; Jakse N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e1-6. PubMed ID: 21112522
[TBL] [Abstract][Full Text] [Related]
5. A preliminary report about treatment of bisphosphonate related osteonecrosis of the jaw with Er:YAG laser ablation.
Stübinger S; Dissmann JP; Pinho NC; Saldamli B; Seitz O; Sader R
Lasers Surg Med; 2009 Jan; 41(1):26-30. PubMed ID: 19143020
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
Williamson RA
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
[TBL] [Abstract][Full Text] [Related]
7. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
[TBL] [Abstract][Full Text] [Related]
8. Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment.
Vescovi P; Merigo E; Meleti M; Fornaini C; Nammour S; Manfredi M
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):628-32. PubMed ID: 17524535
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates and the dental practitioner--a guide to management.
Williamson R
Ann R Australas Coll Dent Surg; 2010 Mar; 20():46-9. PubMed ID: 22046734
[TBL] [Abstract][Full Text] [Related]
10. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
Favia G; Pilolli GP; Maiorano E
J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
14. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Merigo E; Manfredi M; Meleti M; Guidotti R; Ripasarti A; Zanzucchi E; D'Aleo P; Corradi D; Corcione L; Sesenna E; Ferrari S; Poli T; Bonaninil M; Vescovi P
Acta Biomed; 2006 Aug; 77(2):109-17. PubMed ID: 17172192
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
16. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws.
Biasotto M; Chiandussi S; Dore F; Rinaldi A; Rizzardi C; Cavalli F; Di Lenarda R
Acta Odontol Scand; 2006 Nov; 64(6):348-54. PubMed ID: 17123911
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
[TBL] [Abstract][Full Text] [Related]
18. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
19. Alveolar bone and the bisphosphonates.
Cheng A; Daly CG; Logan RM; Stein B; Goss AN
Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]